Intensive tobacco treatment for cancer patients
CORE: CO Monitoring for Reach and Efficacy in Tobacco Treatment for Cancer Patients
This study tests if a special tobacco treatment program helps cancer patients who smoke quit smoking better than regular care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Dartmouth-Hitchcock Medical Center Academic / other |
| Locations | 1 site (Lebanon, New Hampshire) |
| Trial ID | NCT04675515 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of an intensive tobacco treatment program for cancer patients who smoke, measuring cessation success rates at 30 days, 3 months, and 6 months. It employs a mixed-methods, observational cohort approach, where eligible patients at the NCCC are offered carbon monoxide monitoring as part of their treatment. The study compares the cessation rates of those receiving intensive treatment to those receiving usual care and historical controls, without randomization or blinding.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are active smokers at the time of their initial cancer consultation.
Not a fit: Patients who are unable to consent or are incarcerated will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve smoking cessation rates among cancer patients, enhancing their overall treatment outcomes.
How similar studies have performed: Other studies have shown success with intensive tobacco treatment programs in various populations, suggesting potential effectiveness in this context as well.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults age 18 and older * Active Smoker at the time of initial consultation for cancer (defined as any smoking within 2 weeks of consult) Exclusion Criteria: * Adults unable to consent * Prisoners
Where this trial is running
Lebanon, New Hampshire
- Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire, United States (Recruiting)
Study contacts
- Principal investigator: Joseph D Phillips, MD — Dartmouth-Hitchcock Medical Center
- Study coordinator: Joseph D Phillips, MD
- Email: Joseph.D.PHillips@hitchcock.org
- Phone: 603-650-8537
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.